Updated: Springer journal on hold for “pattern of inappropriate and compromised peer review”

Springer has put a cell biology journal on hold, “effective immediately,” after finding a “pattern of inappropriate and compromised peer review.” Here’s the brief statement from the publisher:

PLoS ONE mega-correction, but no retraction, for researcher who sued diabetes journal

PLoS ONE has just issued a 12-figure correction on a paper by Mario A. Saad, who sued the American Diabetes Association unsuccessfully in an attempt to prevent it from retracting four papers in its flagship journal Diabetes. The corrections include taking out Western blots copied from another Saad paper, as well as several figures where the bands … Continue reading PLoS ONE mega-correction, but no retraction, for researcher who sued diabetes journal

Several chem journals neutralize papers from Brazil group over figure fraud

Several journals have retracted or corrected papers from a group at State University of Maringá in Brazil over what one chemistry journal calls “fraudulent use” of figures previously published by the authors. Química Nova, which is retracting a 2013 paper, issued a notice that taps an additional eight articles with Angelica Lazarin as the corresponding author … Continue reading Several chem journals neutralize papers from Brazil group over figure fraud

Rebirth of ovary article prompts retraction from OB lit

The European Journal of Obstetrics & Gynecology and Reproductive Biology has retracted a 2014 paper on polycystic ovary syndrome for self-plagiarism. In the notice, the journal states that “significant portions” of the findings in “Association of anti-Mullerian hormone and small-dense low-density lipoprotein cholesterol with hepatosteatosis in young lean women with and without polycystic ovary syndrome” … Continue reading Rebirth of ovary article prompts retraction from OB lit

Weekend reads: Tortured reviewers, why failure is good, journals without editors?

This week at Retraction Watch, an explosives paper burned up, and we found that we’re cited in a $8 million lawsuit. Here’s what’s happening elsewhere:

IP lawyer/plagiarist’s PhD thesis under review

The Queen Mary University of London has withdrawn the PhD thesis of an intellectual property lawyer who was previously accused of plagiarism. We first covered Angela Adrian last year, when she lost three papers on how to apply intellectual property laws and ideas in the age of the internet. (The irony did not escape Adam, who linked … Continue reading IP lawyer/plagiarist’s PhD thesis under review

Figure dupe sinks cell bio paper

Tulane researchers Tong Wu and Chang Han, who have been anonymously accused of figure duplication in the past, have now finally lost a paper for that reason. The frequent plagiarism tipster Juuichi Jigen (a pseudonym) set up a blog in 2012 alleging that the pair inappropriately reused images in six other papers, though none of those … Continue reading Figure dupe sinks cell bio paper

Diabetes researcher sues journal to prevent retractions of papers cited more than 600 times

Mario A. Saad, who last year retracted a paper for plagiarism, is now suing the American Diabetes Association over four expressions of concern in its flagship journal, Diabetes. As reported in the Boston Business Journal, Saad’s lawsuit claims that his institution, the State University of Campinas, investigated two articles at the journal’s behest. The American Diabetes … Continue reading Diabetes researcher sues journal to prevent retractions of papers cited more than 600 times

Weekend reads: Where to submit your next paper, NIH proposes “emeritus” award, research dollars wasted

This week at Retraction Watch featured the debut of our new editor, and a unicorn. Here’s what was happening elsewhere:

Heart study bleeds into three papers, one retracted and one withdrawn

With the increasingly hectic pace of modern life, everybody is always on the look out for time-saving tricks and tips. Scientists at the National University of Singapore and the Hong Kong Polytechnic University certainly found one, but we really can’t recommend it: doing one randomized controlled trial (RCT) with several outcomes, and publishing them as three separate … Continue reading Heart study bleeds into three papers, one retracted and one withdrawn